Sartorius Receives Renowned Frost & Sullivan Award for Growth Strategy
The international consulting company Frost & Sullivan announced that it will confer the "2006 Growth Strategy Leadership Award" in the market segment of moisture analysis to the Sartorius Group. Before selecting Sartorius, Frost & Sullivan had conducted a comprehensive analysis of world
physical properties instrumentation markets. As part of this analysis, numerous interviews with customers and users were conducted, and the growth strategies of the market participants as well as secondary sources were analyzed.
Frost & Sullivan emphasized in explaining its selection that Sartorius succeeded in considerably increasing its global market share in moisture analysis in 2005. In particular, Sartorius set itself apart from the competition by providing extensive application support services. By making acquisitions in the USA (Sartorius Instrument Omnimark Corp. | Denver Instrument, Inc.), the company also extended its regional presence and customer base. Moreover, through intensive cooperation with scientific institutes, Sartorius sets the standards in new measurement procedures and technologies.
Sartorius has signed an agreement to acquire parts of Danaher’s Life Science Portfolio for approximately $750 million in cash. The businesses had combined sales turnover of approximately $140 million in 2018 with a strong growth profile and double-Digit profit margins. They employ around 30 ... more
Sartorius performed dynamically in the third quarter as well, achieving double-digit growth rates in sales revenue, order intake and earnings in the first nine months.
“Sartorius achieved significant double-digit growth rates in sales revenue and earnings for the first nine months of the ye ... more
Sartorius started off fiscal 2019 with substantial double-digit growth in order intake, sales revenue and earnings. Consolidated first-quarter sales revenue rose in constant currencies by 16.8% to 435.7 million reported: 19.4%); order intake increased 16.6% to 482.8 million euros (reported ... more
Key Benefits of the Cubis II include:
Choose from among 45 weighing modules, two modern user interfaces, several draft shields, and more than 60 software application for thousands of different possible configurations
Choose from our adaptable, preconfigured software ... more
Don’t Worry About False Positives – Instead Obtain Reliable Results Within 3 Hours:
Time-saving by avoiding lengthy 14 day (for sterility) or 28 days (for Mycoplasma) cultivation protocols.
Ensures the highest level of qPCR specificity through use of TaqMan® probes.
No need to perform unce ... more
Join our team This is an exciting opportunity for an experienced Technology Consultant (m/f/d) to join our Marketing BPS division. Besides an agile, vibrant working environment and many more benefits, you will have a chance to grow with the product. You will be part of a new and highly prof ... more
For our Marketing BPS unit we are looking for a Teamlead (m/f/d) of Project Management Validation Service in Goettingen. Our products enable the biopharmaceutical industry to be at the forefront in the development and advancement of treatments for serious diseases. Earning sales revenue of ... more
Sartorius is a leading international partner of the biopharmaceutical industry and the research sector. Sartorius is a dynamic organization suited to people who want to showcase skills, be recognised for expertise, while thriving in a vibrant and innovative environment. Sourcing Manager (m/ ... more
The Sartorius Group is a leading international laboratory and process technology provider covering the segments of biotechnology and mechatronics.
Founded in 1870, the Goettingen-based company currently employs more than 4,500 persons.
The major areas of activity in its biotechnology seg ... more
In recent years, the global pharmaceutical and biotechnology industry has outperformed other sectors in terms of stock market indices. The appeal of orphan drugs and systems that reduce the cost of healthcare will continue to attract investors to fund the industry.Analysis from Frost & Sull ... more
Autografts, the gold standard of bone grafts, have several limitations. As a result, new orthobiologics products are being developed for the benefit of patients as well as surgeons. Innovations in biomaterials and graft design have enabled these advanced products that mimic the natural huma ... more
The use of small animal models in basic and preclinical research is now an integral part of developing and testing new pharmaceutical drugs prior to commercialisation. Small animal imaging is an efficient and cost-effective research platform for the timely validation and commercialisation o ... more